MHRA homes in on personalised healthcare and tech in new 2030 strategy

The MHRA’s new 2030 strategy plans to make drug and device regulation more efficient and patient centric by using technologies like AI. The new strategy focuses on making the MHRA’s drug and device regulation more efficient and patient centric with the use of technologies like AI. The MHRA’s 2030 Strategy is designed to help the agency keep up with the evolving use of AI and data in the life sciences space. Credit: Panya_photo / Shutterstock.com. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has devised a new strategy to better harness advancements in personalised healthcare and technology, facilitating improved…

Source: Clinical Trials Arena